Status:
COMPLETED
Antibiotic Stewardship and Infection Control in Patients at High Risk of Developing Infection by Clostridium Difficile, Vancomycin-Resistant Enterococci or Multi-Resistant Gram-Negatives
Lead Sponsor:
University Hospital of Cologne
Collaborating Sponsors:
Charite University, Berlin, Germany
University Hospital Freiburg
Conditions:
Clostridium Difficile Infection
VRE Infection
Eligibility:
All Genders
18+ years
Brief Summary
Throughout project, the investigators design, evaluate and disseminate infection control and antibiotic stewardship (ABS) measures aimed at reducing the incidence of Clostridium difficile infection (C...
Detailed Description
In recent years, a distinct group of healthcare-associated pathogens (HPs) has become highly prevalent among hospital inpatients worldwide. Clostridium difficile, vancomycin-resistant enterococci (VRE...
Eligibility Criteria
Inclusion
- \- patients admitted to departments with high incidence of CDI, i.e. a) hematology/oncology, b) other departments/wards demonstrating above-average infection rates (identified by previous studies)
Exclusion
- \- patients admitted in opthalmology, paediatrics, psychiatry
Key Trial Info
Start Date :
November 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
80000 Patients enrolled
Trial Details
Trial ID
NCT03250104
Start Date
November 1 2016
End Date
July 1 2019
Last Update
July 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Cologne
Cologne, North Rhine-Westphalia, Germany, 50931